Cipla HIV Drugs Back on WHO Approved List
245726
Two generic drug products by the Indian drug maker Cipla for treating HIV/AIDS have been reinstated on the World Health Organization's recommended list six months after being removed, a senior WHO official said on Tuesday.
185904
The number of AIDS patients receiving  life-extending drugs in poor countries has jumped to 700,000  from 440,000 six months ago, U.N. agencies said on Wednesday,  but warned much more needed to be done.
380559
MONDAY, Jan. 21 (HealthDay News) -- The anti-HIV medication entravirine has been approved by the U.S. Food and Drug Administration for adults who have failed treatment with other antiretrovirals.
212798
NEW YORK, December 16  - Specialty pharmaceutical company Sepracor (SEPR.NAS) announced yesterday that it had received the FDA approval for marketing its Lunesta treatment for insomnia.
514915
The World Health Organization (WHO) said  it would continue recommending use of the Viramune drug in AIDS  patients despite a U.S. regulatory warning, as the benefits  were greater than toxicity problems.
658247
Press Secretary Scott McClellan notes the drug, nevirapine, is still approved for use in America, but he acknowledged the National Institutes of Health has ordered a study of the drug because of concerns it may cause resistance in patients who use it.
294745
People who suffer from insomnia can rest easier now with the approval of a new sleeping pill by Sepracor, called Lunesta. The drug, which can be taken without time restrictions offers a good night&#39;s sleep
371960
Clinical trials of a new microbicide gel designed to help prevent women contracting HIV are stopped.
587506
South African AIDS activists said on Wednesday they hoped clinical trials of a microbicide gel designed to help women protect themselves against HIV could restart after they were halted last month by a U.S. group.
529230
Following an inspection by the World Health Organization (WHO), Indian generic manufacturer Hetero Drugs is withdrawing six antiretrovirals from the WHO prequalification list in order to review data on their bioequivalence.
211992
Doctors and AIDS activists in Africa are worried governments may halt use of an AIDS drug that has protected thousands of babies from HIV infection in reaction to new concerns about the drug's testing and effect on pregnant women.
438501
Here's what a newly approved drug looks like.
711430
ViroPharma completes preliminary enrollment in a study of one of its drug candidates.
539847
GENEVA - India&#39;s Hetero Drugs is withdrawing six of its generic versions of antiretroviral drugs from the World Health Organization&#39;s list of approved HIV medicines, saying it is not certain they are biologically the same as the patented drugs.
182662
Ranbaxy Laboratories on Wednesday said the removal of its anti-AIDS drugs from the UN approved list will not have any impact on its top line or bottomline.
660779
SYDNEY, Australia -- Access to life-extending HIV/AIDS drugs in developing countries has improved during the past three years, but new infections still dramatically outpace efforts to bring treatment to patients, health officials said Monday.
670469
Cipla and Ranbaxy Laboratories agreed to make 19 different anti-retroviral drugs designed for children available at an average price of 16 cents a day, or $60 a year.